237 related articles for article (PubMed ID: 36516551)
1. Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic.
Kleinman RA; Sanches M
Drug Alcohol Depend; 2023 Jan; 242():109703. PubMed ID: 36516551
[TBL] [Abstract][Full Text] [Related]
2. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.
Brothers S; Viera A; Heimer R
J Subst Abuse Treat; 2021 Dec; 131():108449. PubMed ID: 34098303
[TBL] [Abstract][Full Text] [Related]
3. Racial, Ethnic, and Sex Differences in Methadone-Involved Overdose Deaths Before and After the US Federal Policy Change Expanding Take-home Methadone Doses.
Harris RA; Long JA; Bao Y; Mandell DS
JAMA Health Forum; 2023 Jun; 4(6):e231235. PubMed ID: 37294585
[TBL] [Abstract][Full Text] [Related]
4. Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic.
Tanz LJ; Jones CM; Davis NL; Compton WM; Baldwin GT; Han B; Volkow ND
JAMA Netw Open; 2023 Jan; 6(1):e2251856. PubMed ID: 36662523
[TBL] [Abstract][Full Text] [Related]
5. Examination of methadone involved overdoses during the COVID-19 pandemic.
Kaufman DE; Kennalley AL; McCall KL; Piper BJ
Forensic Sci Int; 2023 Mar; 344():111579. PubMed ID: 36739850
[TBL] [Abstract][Full Text] [Related]
6. Estimating the uncertain effect of the COVID pandemic on drug overdoses.
Moghtaderi A; Zocchi MS; Pines JM; Venkat A; Black B
PLoS One; 2023; 18(8):e0281227. PubMed ID: 37561686
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas.
Rezaeiahari M; Fairman BJ
Int J Drug Policy; 2022 Nov; 109():103836. PubMed ID: 36027767
[TBL] [Abstract][Full Text] [Related]
8. Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA.
Zang X; Walley AY; Chatterjee A; Kimmel SD; Morgan JR; Murphy SM; Linas BP; Nolen S; Reilly B; Urquhart C; Schackman BR; Marshall BDL
Addiction; 2023 Dec; 118(12):2413-2423. PubMed ID: 37640687
[TBL] [Abstract][Full Text] [Related]
9. Opioid overdose decedent characteristics during COVID-19.
Garcia GP; Stringfellow EJ; DiGennaro C; Poellinger N; Wood J; Wakeman S; Jalali MS
Ann Med; 2022 Dec; 54(1):1081-1088. PubMed ID: 35467475
[TBL] [Abstract][Full Text] [Related]
10. "The idea is to help people achieve greater success and liberty": A qualitative study of expanded methadone take-home access in opioid use disorder treatment.
Suen LW; Castellanos S; Joshi N; Satterwhite S; Knight KR
Subst Abus; 2022; 43(1):1143-1150. PubMed ID: 35499469
[No Abstract] [Full Text] [Related]
11. Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic.
Kennalley AL; Fanelli JL; Furst JA; Mynarski NJ; Jarvis MA; Nichols SD; McCall KL; Piper BJ
BMJ Open; 2023 Nov; 13(11):e074845. PubMed ID: 37973543
[TBL] [Abstract][Full Text] [Related]
12. Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone.
Kline A; Williams JM; Steinberg ML; Mattern D; Chesin M; Borys S; Chaguturu V
J Subst Use Addict Treat; 2023 Jun; 149():209028. PubMed ID: 37003539
[TBL] [Abstract][Full Text] [Related]
13. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
[TBL] [Abstract][Full Text] [Related]
14. Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs.
Jones CM; Compton WM; Han B; Baldwin G; Volkow ND
JAMA Psychiatry; 2022 Sep; 79(9):932-934. PubMed ID: 35830198
[TBL] [Abstract][Full Text] [Related]
15. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
[TBL] [Abstract][Full Text] [Related]
16. Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.
Rudd RA; Aleshire N; Zibbell JE; Gladden RM
MMWR Morb Mortal Wkly Rep; 2016 Jan; 64(50-51):1378-82. PubMed ID: 26720857
[TBL] [Abstract][Full Text] [Related]
17. Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
Gomes T; Campbell TJ; Kitchen SA; Garg R; Bozinoff N; Men S; Tadrous M; Munro C; Antoniou T; Werb D; Wyman J
JAMA; 2022 Mar; 327(9):846-855. PubMed ID: 35230394
[TBL] [Abstract][Full Text] [Related]
18. History of Methadone and Buprenorphine Opioid Agonist Therapy Among People Who Died of an Accidental Opioid-Involved Overdose: Rhode Island, January 1, 2018-June 30, 2020.
Hallowell BD; Weidele HR; Daly M; Chambers LC; Scagos RP; Gargano L; McDonald J
Am J Public Health; 2021 Sep; 111(9):1600-1603. PubMed ID: 34410818
[TBL] [Abstract][Full Text] [Related]
19. Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States.
Auty SG; Griffith KN
Drug Alcohol Depend; 2022 Mar; 232():109340. PubMed ID: 35131533
[TBL] [Abstract][Full Text] [Related]
20. Alcohol or Benzodiazepine Co-involvement With Opioid Overdose Deaths in the United States, 1999-2017.
Tori ME; Larochelle MR; Naimi TS
JAMA Netw Open; 2020 Apr; 3(4):e202361. PubMed ID: 32271389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
